Pharmacyclics, Inc. (NASSDAQ:PCYC) And Servier Strike Deal To End Collaboration On Pan-HDAC Inhibitor

Boston, MA 09/26/2014 (wallstreetpr) – Biopharmaceutical company, Pharmacyclics, Inc. (NASDAQ:PCYC) disclosed that it has struck an agreement with French pharmaceutical company, Servier, paving the way for ending the collaboration relating to pan-HDAC inhibitor compounds. Collaboration Ends The company said that the agreement was mutual and amicable, its statement indicated. As a result, abexinostat compound would […]